Target intelligence / Profile preview

POU domain class 5 transcription factor 1 (OCT4)

Target
OCT4
Molecular classification
Transcription factor [1, 5], POU domain protein [5, 14], Homeobox protein [2, 5]
01

Overview

POU domain class 5 transcription factor 1, widely known as OCT4, is a master regulator of pluripotency and self-renewal in embryonic stem cells and germ cells [1, 3, 5]. It functions by binding to specific octamer DNA motifs and forming synergistic complexes with other factors like SOX2 and NANOG to maintain an undifferentiated cellular state [5, 9, 10]. While typically silenced in adult somatic tissues, its aberrant re-expression is a hallmark of cancer stem cells (CSCs) in various malignancies, including germ cell tumors, lung, bladder, and breast cancers [2, 11, 21]. In the tumor microenvironment, OCT4 activity drives proliferation, metastasis, and acquired resistance to chemotherapeutic agents like cisplatin [12, 13, 21]. Therapeutic strategies, such as using all-trans retinoic acid to repress OCT4 transcription, aim to sensitize tumors to treatment by eradicating the resilient stem cell-like population [12].

Other names
POU5F1OCT3Oct-3/4OTF3Octamer-binding transcription factor 4Octamer-binding protein 3Octamer-binding protein 4POU class 5 homeobox 1OTF-3OTF4
02

Mechanism of action

Transcriptional repression of stemness genes and inhibition of cancer stem cell maintenance [7, 12].

03

Biological functions

Stem cell pluripotency maintenance [1, 5]Self-renewal of undifferentiated cells [3, 10]Early embryogenesis [5, 16]Somatic cell reprogramming [3, 5]Transcriptional regulation [5, 19]Cell cycle regulation [14]Apoptosis inhibition [6, 14]
04

Disease associations

Cancer [1, 11]Germ cell tumor [11]Chemoresistance [12, 13]Tumor metastasis [4, 13]Tumorigenesis [2, 13]
05

Safety considerations

Risk of teratoma formation from uncontrolled pluripotency [18]Developmental toxicity [1, 11]Cell fate instability due to narrow concentration requirements [1, 17]Essentiality for early embryogenesis [5, 11]
06

Interacting drugs

All-trans retinoic acid [12]

1 more in the full profile.

07

Biomarkers

OCT4 expression [1, 11]Cancer stem cell (CSC) presence [10, 21]Germ cell tumor differentiation status [11]Nanog/SOX2 co-expression [10, 14]

Beyond the preview

Go deeper on POU domain class 5 transcription factor 1 (OCT4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on POU domain class 5 transcription factor 1 (OCT4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call